UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids

Journal of lipid research, 1998-05, Vol.39 (5), p.1062-1070

1998

Volltextzugriff (PDF)

Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-Isoprostane formation in hypercholesterolemic subjects no further effect of vitamin E

Circulation (New York, N.Y.), 2002-11, Vol.106 (20), p.2543-2549

2002

Volltextzugriff (PDF)

Low-Density Lipoprotein Level Reduction by the 3-Hydroxy-3-Methylglutaryl Coenzyme-A Inhibitor Simvastatin Is Accompanied by a Related Reduction of F 2 -Isoprostane Formation in Hypercholesterolemic Subjects: No Further Effect of Vitamin E

Circulation (New York, N.Y.), 2002-11, Vol.106 (20), p.2543-2549

2002

Volltextzugriff (PDF)

Platelet-vessel wall interactions with third-generation oral contraceptives: no evidence of detrimental effects

Thrombosis and haemostasis, 1999-09, Vol.82 (3), p.1164

1999

Volltextzugriff (PDF)

Soluble e-selectin in essential hypertension: a correlate of vascular structural changes

American journal of hypertension, 2001-03, Vol.14 (3), p.259-266

2001

Volltextzugriff (PDF)

111 In Platelet Scintigraphy for the Noninvasive Detection of Carotid Plaque Thrombosis

Stroke (1970), 2001-03, Vol.32 (3), p.719-727

2001

Volltextzugriff (PDF)

n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease

Kidney international, 1993-10, Vol.44 (4), p.843-850

1993

Volltextzugriff (PDF)

Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery

Circulation (New York, N.Y.), 1990-08, Vol.82 (2), p.428-438

1990

Volltextzugriff (PDF)

111In platelet scintigraphy for the noninvasive detection of carotid plaque thrombosis

Stroke (1970), 2001-03, Vol.32 (3), p.719-727

2001

Volltextzugriff (PDF)

Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids1

Journal of lipid research, 1998-05, Vol.39 (5), p.1062-1070

1998

Volltextzugriff (PDF)

Platelet radiolabelling with 111Indium for in vivo studies: A methodological reappraisal

Nuclear medicine and biology, 1995-04, Vol.22 (3), p.399-403

1995

Volltextzugriff (PDF)

Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin

Thrombosis and haemostasis, 1991-05, Vol.65 (5), p.504

1991

Volltextzugriff (PDF)

Prevalence of anticardiolipin antibodies in coronary artery disease

The American journal of cardiology, 1990-04, Vol.65 (13), p.922-923

1990

Volltextzugriff (PDF)

Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates

Thrombosis and haemostasis, 1988-04, Vol.59 (2), p.207

1988

Volltextzugriff (PDF)

The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man

Thrombosis and haemostasis, 1992, Vol.67 (2), p.258

1992

Volltextzugriff (PDF)

Omega-3 fatty acid supplementation and lipoprotein(a) concentrations in patients with chronic glomerular diseases

Nephron (2015), 1996, Vol.72 (3), p.383

1996

Volltextzugriff (PDF)

Inhibition of platelet function during in vivo infusion of isosorbide mononitrates: Relationship between plasma drug concentration and hemodynamic effects

The American heart journal, 1990-04, Vol.119 (4), p.855-862

1990

Volltextzugriff (PDF)

Effects of radiologic contrast media on eicosanoid production from cells involved in hemostasis and thrombosis

Seminars in hematology, 1991-10, Vol.28 (4 Suppl 7), p.49-53; discussion 66-8

1991

Volltextzugriff (PDF)

Inhibition of platelet function by injectable isosorbide dinitrate

The American journal of cardiology, 1984-06, Vol.53 (11), p.1683-1687

1984

Volltextzugriff (PDF)

Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent

Thrombosis research, 1985-01, Vol.37 (2), p.337-342

1985

Volltextzugriff (PDF)

Inhibition of platelet aggregation and thromboxane B 2 production during aspirin treatment: Dependence on the dose of the aggregating agent

Thrombosis research, 1985, Vol.37 (2), p.337-342

1985

Volltextzugriff (PDF)

Antiplatelet effects of verapamil in man

The American journal of cardiology, 1981, Vol.47, p.399-399

1981

Volltextzugriff (PDF)

Iloprost in Prinzmetal's angina

The American journal of cardiology, 1986-09, Vol.58 (6), p.553-554

1986

Volltextzugriff (PDF)

Selective inhibition of thromboxane-related platelet function by low-dose aspirin in patients after myocardial infarction

The American journal of cardiology, 1985-02, Vol.55 (5), p.589-590

1985

Volltextzugriff (PDF)

Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper

Pharmacological research, 2018-08, Vol.134, p.51-60

2018

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(27)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids

Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-Isoprostane formation in hypercholesterolemic subjects no further effect of vitamin E

Low-Density Lipoprotein Level Reduction by the 3-Hydroxy-3-Methylglutaryl Coenzyme-A Inhibitor Simvastatin Is Accompanied by a Related Reduction of F 2 -Isoprostane Formation in Hypercholesterolemic Subjects: No Further Effect of Vitamin E

Platelet-vessel wall interactions with third-generation oral contraceptives: no evidence of detrimental effects

Soluble e-selectin in essential hypertension: a correlate of vascular structural changes

111 In Platelet Scintigraphy for the Noninvasive Detection of Carotid Plaque Thrombosis

n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease

Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery

111In platelet scintigraphy for the noninvasive detection of carotid plaque thrombosis

Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids1

Platelet radiolabelling with 111Indium for in vivo studies: A methodological reappraisal

Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin

Prevalence of anticardiolipin antibodies in coronary artery disease

Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates

The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man

Omega-3 fatty acid supplementation and lipoprotein(a) concentrations in patients with chronic glomerular diseases

Inhibition of platelet function during in vivo infusion of isosorbide mononitrates: Relationship between plasma drug concentration and hemodynamic effects

Effects of radiologic contrast media on eicosanoid production from cells involved in hemostasis and thrombosis

Inhibition of platelet function by injectable isosorbide dinitrate

Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent

Inhibition of platelet aggregation and thromboxane B 2 production during aspirin treatment: Dependence on the dose of the aggregating agent

Antiplatelet effects of verapamil in man

Iloprost in Prinzmetal's angina

Selective inhibition of thromboxane-related platelet function by low-dose aspirin in patients after myocardial infarction

Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper

Suchergebnisse filtern